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PP-091 Non-speciﬁc immune therapy and hepatitis B and
chronic asymptomatic carriers to obtain HBV-DNA
negative effect relationship
Zu-liang Han*, Yu-sheng Sun, Xin-qi Li. Huang Pu People’s
Hospital,Zhongshan,Guangdong
Objective: Observation of chronic hepatitis B and asymptomatic
carriers to obtain HBV-DNA negative efﬁcacy and non-speciﬁc
immune response relationship.
Methods: 255 cases of patients will be divided into 4 group;
observation lamivudine and Mycobacterium FU36 with Chinese
medicine group (A) and lamivudine with the Chinese group (B),
HBV-DNA on the efﬁcacy, safety and efﬁcacy issues, 3 month
course of treatment, follow-up 9 months.
Results: 1) B group of chronic hepatitis B have HBV-DNA, re-
spectively, 30.30% and 26.47% of the signiﬁcant efﬁciency, it was
signiﬁcantly higher than non-carriers of asymptomatic has a case
to obtain the effect markedly, P<0,01; 2) A group of chronic
hepatitis B in HBV-DNA were 82.75% and 76.66% of the signiﬁcant
efﬁciency, was signiﬁcantly higher than group B, only 30.30% and
26.47% efﬁciency of the signiﬁcant, P <0,01; 3) A group of HBeAg
negative carriers of asymptomatic HBV-DNA has the remarkable
efﬁciency of 80.64%, signiﬁcantly higher than the B group is
not an case,A group of HBeAg-positive carriers of asymptomatic
HBV-DNA, only 5.71% of the signiﬁcant efﬁciency, P<0,01, etc.
Course of treatment there is no adverse reaction.
Conclusions: Non-speciﬁc immune status changes, and abnormal
alanine aminotransferase, and HBV-DNA was markedly effect the
results signiﬁcantly correlated, induced HBeAg-speciﬁc immune
tolerance of HBV-DNA to obtain the effect of markedly present
only for the “impact” role.
PP-092 Novel role of peripheral blood mononuclear cells
in HBV intrauterine infection
Yuan-Yong Xu*,1, Hui-Hui Liu2, Hong-Bin Song1, Liu-Yu Huang1,
Lei-Li Jia1, Chuan-Fu Zhang1. 1Institute of Disease Control and
Prevention of PLA; 2Chinese Center for Disease Control and
Prevention
Background & aims: Intrauterine infection by HBV represents
an integral cause for the failure of hepatitis B vaccines. This
study aimed at appreciating the role played by PBMC in HBV
intrauterine infection.
Methods: Serum samples were taken from study subjects to
detect HBsAg, HBV DNA in serum and in PBMC. For mother-to-
fetus PBMC transfer,AS-PCR and heminested-PCR assays for inser-
tion/deletion polymorphisms involving glutathione S-transferase
M1 (GSM1) and angiotensin-converting enzyme (ACE) were em-
ployed.
Results: A total of 119 mother-baby pairs were identiﬁed as
clinically informative cases from 312 mothers and their newborn
infants. 75 showed HBV-infected PBMC trafﬁc from mother to
fetus. Among these 75 infants, 61 were HBV-infected intrauter-
inely, and 57 carried HBV-infected PBMC. Statistical analysis
demonstrated that maternal PBMC HBV infection was associ-
ated with HBV intrauterine infection (OR=4.20, 95% CI:2.01-8.85;
P<0.01). Our date suggested that PBMC transfer from mother to
fetus was positively connected with the risk of HBV intrauterine
infection (OR=8.42, 95% CI: 3.32-21.61; p<0.0001). Such fetoma-
ternal PBMC transfer was also positively allied with the risk of
HBV infection of PBMC in infants (OR=9.51, 95%CI: 3.71-24.91;
p<0.0001). However, no signiﬁcant association was found be-
tween mother-to-fetus PBMC transmission and the newborns’
serum HBV DNA or HBsAg positivity.
Conclusions: Our results are supportive of the conclusion that
maternal PBMCs infected with HBV contribute to HBV intrauter-
ine infection of newborn infants by transferring from mother to
fetus.
PP-093 Analysis of genes ralted to cholesterol
metabolism differentially expressed in HepG2
cells transfected with HBV-replicon
Jinqian Zhang*, Xiaobin Chen. Institute of Infectious Diseases,
Beijing Ditan Hospital, Capital University of Medical
Background: To explore the changes in gene expressions in the
HepG2 cell transfected by HBV replicon.
Method: A 22000 gene DNA microarray was used to examine
gene expressions in the HepG2 cell transfected by HBV replicon.
The differentially expressed genes were identiﬁed and some
genes which maybe contribute to Cholesterol metabolism were
subjected to realtime PCR analysis.
Result: The differentially expressed genes mostly involved in
transcription regulatory molecules, cytokines, signal transduc-
tion, protein,glucose, lipid metabolism. The results of Real-time
PCR of 7DCR, NADH-b5R were consistent with that of genechip
analysis.
Conclusion: Microarray expression proﬁle of HepG2 cell trans-
fected by HBV replicon is differential. 7DCR, NADH-b5R may play
an important role in cholesterol metabolism.
PP-094 Screening of the target genes transactivated by
PS1TP2 protein with suppression subtractive
hybridization technique
Jiang Guo*. Institute of Infectious Diseases, Beijing Ditan
Hospital, Beijing, China
Background: To construct a subtractive cDNA library of genes
transactivated by PS1TP2 protein with suppression subtractive
hybridization (SSH) technique and clone genes associated with
transactivation.
Methods: Suppression subtractive hybridization technique and
bioinformatics technique were used, the mRNA was isolated
from HepG2 cells transfected with pcDNA3.1(–)-PS1TP2 and
pcDNA3.1(–) empty vector respectively; cDNA was synthesized.
After digestion with restriction enzyme RsaI, cDNA fragments
were obtained. Tester cDNA was then divided into two groups
and ligated to the speciﬁc adaptor 1 and adaptor 2 respectively.
After tester cDNA was hybridized with driver cDNA twice and
underwent two times of nested PCR, ampliﬁed cDNA fragments
were subcloned into pGEM-Teasy vectors to set up the subtractive
library. Ampliﬁcation of the library was carried out with E. coli
strain DH5α. The cDNA was sequenced and analyzed in GenBank
with Blast search after PCR.
Results: The subtractive library of genes transactivated by
PS1TP2 was constructed successfully.The ampliﬁed library con-
tains 90 positive clones.Colony PCR showed that 60 clones con-
tain 200∼1000 bp inserts. Sequence analysis was performed in
25 clones randomly, and the full length sequences were obtained
with bioinformatics method and searched for homologous DNA
sequence from GenBank, altogether 15 coding sequences were
gotten.
Conclusion: The obtained sequences may be target genes trans-
activated by PS1TP2 protein among which some genes coding
proteins involved in cell cycle regulation, metabolism, immunity
and cell apoptosis. This ﬁnding brought some clues for studying
the biological functions of PS1TP2.
PP-095 Sequence analysis of Hepatitis B Virus S gene ‘a’
epitope in HBV infected patients positive for both
HBsAg and HBsAb
Weilie Chen*, Yizhou Tan, Shaojing Wei, Yangbo Tang, Zhan Yang.
Inst. of Infectious Diseases, 8th People’s Hospital, Guangzhou
Objective: To characterize the sequence of hepatitis B virus S
gene ‘a’ epitope in HBV infected patients positive for HBsAg and
HBsAb.
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Methods: Nested-PCR was used to amplify the HBV S gene and
the PCR products were sequenced directly or sequenced after
cloning, the sequences of ‘a’ epitope were then analyzed by
sequence alignment.
Results: Direct sequencing of PCR products showed that there
was one amino acid (AA) residue in ‘a’ epitope less conserved
region emerged polymorphism in each of all 4 HBV infected
patients with both positive HBsAg and HBsAb markers. Clone
sequencing showed that, the AA residue 126 of ‘a’ epitope in
patient 1 could be Thr, Ile and Ser, the AA residue 134 could be
Phe and Ser; the AA residue 126 in patient 2 could be Ala and
Thr, and patient 3 could be Ile and Asn; AA polymorphism was not
found in patient 4.
Conclusions: Mixture virus may exist in HBV infected patients
positive for HBsAg and HBsAb; the polymorphism of HBV quasi-
species ‘a’ epitope sequence should be one of the reasons caused
both HBsAg and HBsAb positive in HBV infected patients.
PP-096 A retrospective study on risk factors of HBV and
HCV in Esfahan, Iran
Mohammadali Zia*,1, Maryam Rouholamin2, Mostafa Banitaba3.
1Islamic Azad University, Khorasgan Branch; 2Payam-e-Noor
University of Esfahan, Vazvan Center; 3Islamic Azad University,
Naein Branch
Background: The Hepatitis viruses, a heterogenous group of
viruses with a tropism for the liver, are the major cause of viral
hepatitis. HBV and HCV are among the most important agents of
viral hepatitis. These viruses are spread parenterally by blood or
needles, by sexual contact and perinatally and etc.
Methods: 254 patients include 163 HBV and 91 HCV were studied
in this research. This study was carried out using recorded infor-
mation in ﬁle of patients in Tropical and Infectious Research Cen-
ter in Esfahan, and information was extracted from these ﬁles.
Results: The history of:
– surgery: HBV: 71 (28% of all patients) - HCV: 48 (18.9% of all
patients)
– blood transmission: HBV: 15 (6.1% of all patients) - HCV: 16
(6.2% of all patients)
– contact with hepatitis patient: HBV: 36 (14.2% of all patients)
- HCV: 15 (6.1% of all patients)
– accident: HBV: 23 (9% of all patients) - HCV: 20 (7.9% of all
patients)
– tattooing: HBV: 30 (11.8% of all patients) - HCV: 7 (2.75% of all
patients)
– cupping: HBV: 22 (8.66% of all patients) - HCV: 6 (2.4% of all
patients)
– sexual contact: HBV: 21 (8.3% of all patients) - HCV: 1 (0.39%
of all patients)
– renal dialysis: HBV and HCV: 0
Conclusion: It seems that the above mentioned risk factors are
very important in epidemiology of Hepatitis. Therefore efﬁcient
education to population and patients to control and prevention
of disease is necessary.
PP-097 Role of hepatitis B virus genotypes, BCP,
precore/core and X gene mutations and the risk
of hepatocellular carcinoma
Mohammad Asim*,1,2, Sunil Kumar Polipalli 2, Nargis Begum1,2,
Istaq Ahmed1,2, Luqman A. Khan1, S.A. Husain1,
L. Thayumanavan3, P. Kar2. 1Jamia Millia Islamia; 2Maulana
Azad Medical college; 3Madurai Medical College
Objectives: We aimed to characterize mutations of HBV genome
involving X gene, basal core promoter (BCP), and Precore/core
regions and also deﬁne HBV genotypes in patients of HCC from
India.
Methods: HBV genotypes and mutations were determined in 150
HCC and 136 chronic liver disease patients without HCC. All HBV
DNA positive cases were subjected to mutational analysis using
SSCP and genotyping by RFLP.
Results: Amongst 150 HCC patients, 79.4% and 20.6% had geno-
type D and A, respectively. The prevalence of genotype D was
signiﬁcantly higher in HCC patients compared with controls
(p=0.03). The T1484, TT1504, T1653, C1705, C1740, C/G1753,
T1762/A1764, A1896 and G1914 mutations were frequent in HCC
cases. The prevalence of the TT1504 mutation in the X gene,
the V1753 and T1762/A1764 mutations in BCP region and G1914
mutation in core gene were signiﬁcantly higher in the HCC group
compared to controls (48% vs 7%, 44% vs 7%, 70% vs 33% and 41%
vs 6.7%, respectively). Also, T1653 (58% vs 14%) mutation was
signiﬁcantly higher for HCC cases. Multivariate analyses showed
that the TT1504, 1653T, C1705, 1753V, and A1762T G1764A mu-
tations and patient age signiﬁcantly increased the risk of HCC
development. Also HCC had lower levels of serum albumin and
platelet count, but higher values of ALP, AST, ALT, Bilirubin and
AFP compared to controls (P<0.001).
Conclusion: HBV genotype D and the exclusively found preva-
lence of certain mutations detected in those with HBV-related
carcinoma nevertheless indicate a degree of association with
disease progression in Indian patients.
PP-098 Resolved hepatitis B virus infection is associated
with poor prognosis in patients with primary
biliary cirrhosis
Fu-kui Zhang*,1, Ying Zhang1, Jun-yong Zhang2, Xue Li 1,
Ji-dong Jia1, Bao-en Wang1. 1Liver Research Center, Beijing
Friendship Hospital, Capital Medical University, Beijing, China;
2Department of Gastroenterology, Shandong Provincial Hospital,
Shandong University, Ji’nan, China
Objective: To study the prevalence of resolved hepatitis B virus
(HBV) infection in patients with primary biliary cirrhosis (PBC)
and whether the resolved infection is associated with much poor
prognosis.
Methods: Sixty PBC patients with negative serum HBsAg were
further measured for other serum HBV infection markers, in-
cluding anti-HBs, HBeAg, HBeAb, HBcAb and HBV DNA. Patients
with resolved HBV infection were termed as serum HBcAb pos-
itive (±anti-HBs±HBeAb), HBsAg negative and HBV DNA unde-
tectable. The severity of the disease including the occurrence
of hypoalbuminemia and/or jaundice, complications of decom-
pensated cirrhosis/portal hypertension such as ascites, hepatic
encephalopathy, upper gastrointestinal variceal bleeding or the
occurrence of hepatocellular carcinoma was compared between
patients with and without resolved HBV infection.
Results: There were 25 patients (41.7%, 58.9±11.3 yr) with
resolved HBV infection and 35 patients (58.3%, 57.8±11.5 yr)
without resolved HBV infection. Complications of decompen-
sated cirrhosis/portal hypertension or the occurrence of HCC
were more frequently occurred in PBC patients with resolved
HBV infection than patients without resolved HBV infection (72%
vs. 37.14%, P<0.01).
Conclusion: Resolved HBV infection was common in Chinese PBC
patients and may be related with much poor prognosis.
Acknowledgement: The study was supported in part by a grant
from Beijing Municipal Science & Technology Commission, “Bei-
jing Nova Program 2006 B54” to Fukui Zhang.
PP-099 Hepatitis B surface antigen mutation Thr to Met
at position 118 leads to antigenicity change and
causes some blood screening kits failure
Yonglin Yang*,1,2, Bo Meng1, Zhuhu Huang2. 1NanJing Red Cross
Blood Center; 2JiangSu Province Hospital Infectious Department
Background: We found a new point mutation A to T in the HBsAg
